Underactive Bladder
8
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Akyva First In Human
SNM vs. HBOT for Refractory IC/BPS
The Efficacy of Pyridostigmine Therapy After Transurethral Resection of Prostate in Cases with Underactive Urinary Bladder.
A Study of ASP8302 in Participants With Underactive Bladder
Pudendal Nerve Mapping Towards Improved Neuromodulation for Urinary Retention
Previously Implanted Pudendal Nerve Stimulation
The Treatment Efficacy of Prolotherapy in Bladder Voiding Dysfunction
Codesign of an Optical Device to Measure Urine Flow and Volume